171 related articles for article (PubMed ID: 9406346)
1. DNA-based immunization against hepatitis B virus.
Davis HL; Brazolot Millan CL
Springer Semin Immunopathol; 1997; 19(2):195-209. PubMed ID: 9406346
[No Abstract] [Full Text] [Related]
2. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus.
Prince AM; Whalen R; Brotman B
Vaccine; 1997 Jun; 15(8):916-9. PubMed ID: 9234547
[TBL] [Abstract][Full Text] [Related]
3. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells.
Roh S; Kim K
Microbiol Immunol; 2003; 47(6):453-60. PubMed ID: 12906106
[TBL] [Abstract][Full Text] [Related]
4. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
[TBL] [Abstract][Full Text] [Related]
5. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B.
Clark JR; Bartley K; Jepson CD; Craik V; March JB
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):197-204. PubMed ID: 21204995
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies against hepatitis B after vaccination in health workers].
Pérez-López JA; García-Elorriaga G; Del Rey-Pineda G; Manjarrez-Téllez B
Salud Publica Mex; 2011; 53(3):205-6. PubMed ID: 21829884
[No Abstract] [Full Text] [Related]
8. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization.
Fuller JT; Fuller DH; McCabe D; Haynes JR; Widera G
Ann N Y Acad Sci; 1995 Nov; 772():282-4. PubMed ID: 8546409
[No Abstract] [Full Text] [Related]
9. Immune response to intramuscular revaccination after primary intradermal vaccination against hepatitis B.
Pegues DA; Woodruff BA; Lambert SB; Tant MK; Woernle CH
Clin Infect Dis; 1995 Feb; 20(2):335-41. PubMed ID: 7742439
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of Russian vaccines in the prophylaxis of virus hepatitis B].
Solov'eva IL; Kusel'man AI; Kalmanova VP; Kostinov MP
Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):100-5. PubMed ID: 15773414
[TBL] [Abstract][Full Text] [Related]
11. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
Chen H; Zhu QR
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
[No Abstract] [Full Text] [Related]
12. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
Zhou Z; Chen WS; Zhang HH; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccines.
Troisi CL; Hollinger FB
Prog Liver Dis; 1990; 9():405-42. PubMed ID: 2156306
[No Abstract] [Full Text] [Related]
14. [The economic aspects of vaccination against hepatitis B].
Zhiburt EB
Voen Med Zh; 1997 Aug; 318(8):22-4. PubMed ID: 9424810
[No Abstract] [Full Text] [Related]
15. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
[TBL] [Abstract][Full Text] [Related]
16. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.
Michel ML; Loirat D
Intervirology; 2001; 44(2-3):78-87. PubMed ID: 11509869
[TBL] [Abstract][Full Text] [Related]
18. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
[TBL] [Abstract][Full Text] [Related]
19. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
Oka Y; Akbar SM; Horiike N; Joko K; Onji M
Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
[TBL] [Abstract][Full Text] [Related]
20. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
